(Q44969257)

English

BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning

scientific article published in September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 December 2017

BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning (English)

1 reference

Europe PubMed Central

7 December 2017

chronic myeloid leukemia

0 references

1 reference

based on heuristic

inferred from title

12

object named as

R F Storb

1 reference

Europe PubMed Central

7 December 2017

author name string

T Lange

1

1 reference

Europe PubMed Central

7 December 2017

M Deininger

2

1 reference

Europe PubMed Central

7 December 2017

R Brand

3

1 reference

Europe PubMed Central

7 December 2017

U Hegenbart

4

1 reference

Europe PubMed Central

7 December 2017

H Al-Ali

5

1 reference

Europe PubMed Central

7 December 2017

R Krahl

6

1 reference

Europe PubMed Central

7 December 2017

W Poenisch

7

1 reference

Europe PubMed Central

7 December 2017

L Uharek

8

1 reference

Europe PubMed Central

7 December 2017

S Leiblein

9

1 reference

Europe PubMed Central

7 December 2017

C Gentilini

10

1 reference

Europe PubMed Central

7 December 2017

E Petersdorf

11

1 reference

Europe PubMed Central

7 December 2017

D Niederwieser

13

1 reference

Europe PubMed Central

7 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 September 2004

1 reference

Europe PubMed Central

7 December 2017

1 reference

Europe PubMed Central

7 December 2017

18

1 reference

Europe PubMed Central

7 December 2017

9

1 reference

Europe PubMed Central

7 December 2017

1468-1475

1 reference

Europe PubMed Central

7 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403425

0 references

Bone Marrow Transplantation for Patients with Chronic Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

High Bad and Bax mRNA expression correlate with negative outcome in acute myeloid leukemia (AML).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

High levels of BAX, low levels of MRP-1, and high platelets are independent predictors of response to imatinib in myeloid blast crisis of CML.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukaemia patients using real-time quantitative RT-PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

Detection and quantification of residual disease in chronic myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

21 January 2018

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of BCR-ABL expression using real-time RT-PCR in CML after bone marrow or peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

7 January 2021

based on heuristic

inferred from DOI database lookup

The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403425

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2403425

1 reference

Europe PubMed Central

7 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44969257&oldid=2059865607"